Walleye Capital LLC Penumbra Inc Call Options Transaction History

Walleye Capital LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$163.64 - $210.12 $1.44 Million - $1.85 Million	8,800 Added 517.65%	10,500 $2.04 Million
Q2 2024 Aug 14, 2024	SELL	$172.27 - $223.95 $223,951 - $291,135	-1,300 Reduced 43.33%	1,700 $305,000
Q1 2024 May 15, 2024	BUY	$220.09 - $273.15 $22,009 - $27,314	100 Added 3.45%	3,000 $669,000
Q4 2023 Feb 14, 2024	SELL	$181.44 - $260.22 $90,720 - $130,110	-500 Reduced 14.71%	2,900 $729,000
Q3 2023 Nov 14, 2023	SELL	$240.69 - $338.77 $914,622 - $1.29 Million	-3,800 Reduced 52.78%	3,400 $822,000
Q2 2023 Aug 14, 2023	BUY	$271.54 - $344.06 $1.47 Million - $1.86 Million	5,400 Added 300.0%	7,200 $2.48 Million
Q1 2023 May 15, 2023	BUY	$220.43 - $278.69 $396,774 - $501,642	1,800 New	1,800 $501,000

372

29.1M

305K

192K

Ticker PEN
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,888,400
Market Cap $9.01B
Description
Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.